448 related articles for article (PubMed ID: 30319626)
1. Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges.
Lin A; Yan WH
Front Immunol; 2018; 9():2164. PubMed ID: 30319626
[TBL] [Abstract][Full Text] [Related]
2. HLA-G: A New Immune Checkpoint in Cancer?
Krijgsman D; Roelands J; Hendrickx W; Bedognetti D; Kuppen PJK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630545
[TBL] [Abstract][Full Text] [Related]
3. Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape.
Eichmüller SB; Osen W; Mandelboim O; Seliger B
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28383653
[TBL] [Abstract][Full Text] [Related]
4. HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges.
Lin A; Yan WH
Front Immunol; 2021; 12():698677. PubMed ID: 34276691
[TBL] [Abstract][Full Text] [Related]
5. Single-cell RNA sequencing of lung adenocarcinoma reveals heterogeneity of immune response-related genes.
Ma KY; Schonnesen AA; Brock A; Van Den Berg C; Eckhardt SG; Liu Z; Jiang N
JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30821712
[TBL] [Abstract][Full Text] [Related]
6. HLA-G regulators in cancer medicine: an outline of key requirements.
Zidi I; Ben Amor N
Tumour Biol; 2011 Dec; 32(6):1071-86. PubMed ID: 21792710
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers.
Xu HH; Gan J; Xu DP; Li L; Yan WH
Front Immunol; 2021; 12():614773. PubMed ID: 34276642
[TBL] [Abstract][Full Text] [Related]
8. Intratumor Heterogeneity of HLA-G Expression in Cancer Lesions.
Zhang X; Lin A; Han QY; Zhang JG; Chen QY; Ye YH; Zhou WJ; Xu HH; Gan J; Yan WH
Front Immunol; 2020; 11():565759. PubMed ID: 33329527
[TBL] [Abstract][Full Text] [Related]
9. The immunosuppressive molecule HLA-G and its clinical implications.
González A; Rebmann V; LeMaoult J; Horn PA; Carosella ED; Alegre E
Crit Rev Clin Lab Sci; 2012; 49(3):63-84. PubMed ID: 22537084
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathways: human leukocyte antigen G (HLA-G).
Curigliano G; Criscitiello C; Gelao L; Goldhirsch A
Clin Cancer Res; 2013 Oct; 19(20):5564-71. PubMed ID: 23897901
[TBL] [Abstract][Full Text] [Related]
11. In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance.
Loumagne L; Baudhuin J; Favier B; Montespan F; Carosella ED; Rouas-Freiss N
Int J Cancer; 2014 Nov; 135(9):2107-17. PubMed ID: 24623585
[TBL] [Abstract][Full Text] [Related]
12. HLA-G1 and HLA-G5 isoforms have an additive effect on NK cytolysis.
Zhang WQ; Xu DP; Liu D; Li YY; Ruan YY; Lin A; Yan WH
Hum Immunol; 2014 Feb; 75(2):182-9. PubMed ID: 24269702
[TBL] [Abstract][Full Text] [Related]
13. Role of HLA-G in tumors and upon COVID-19 infection.
Seliger B
Hum Immunol; 2024 May; 85(3):110792. PubMed ID: 38555250
[TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigen-G (HLA-G) polymorphism and expression in breast cancer patients.
Jeong S; Park S; Park BW; Park Y; Kwon OJ; Kim HS
PLoS One; 2014; 9(5):e98284. PubMed ID: 24870375
[TBL] [Abstract][Full Text] [Related]
15. Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients.
Tronik-Le Roux D; Renard J; Vérine J; Renault V; Tubacher E; LeMaoult J; Rouas-Freiss N; Deleuze JF; Desgrandschamps F; Carosella ED
Mol Oncol; 2017 Nov; 11(11):1561-1578. PubMed ID: 28815885
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation and mRNA expression of HLA-G in relation to HLA-G protein expression in colorectal cancer.
Swets M; Seneby L; Boot A; van Wezel T; Gelderblom H; van de Velde CJ; van den Elsen PJ; Kuppen PJ
Hum Immunol; 2016 Sep; 77(9):764-72. PubMed ID: 27245757
[TBL] [Abstract][Full Text] [Related]
17. HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers.
Li P; Wang N; Zhang Y; Wang C; Du L
Front Immunol; 2021; 12():791535. PubMed ID: 34868081
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen-G (HLA-G) as a marker for diagnosis, prognosis and tumor immune escape in human malignancies.
Yie SM; Hu Z
Histol Histopathol; 2011 Mar; 26(3):409-20. PubMed ID: 21210353
[TBL] [Abstract][Full Text] [Related]
19. Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients.
Sabbatino F; Liguori L; Polcaro G; Salvato I; Caramori G; Salzano FA; Casolaro V; Stellato C; Col JD; Pepe S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023239
[TBL] [Abstract][Full Text] [Related]
20. Role of microRNAs on HLA-G expression in human tumors.
Seliger B
Hum Immunol; 2016 Sep; 77(9):760-3. PubMed ID: 27142884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
